Shanghai Fosun Long March Med-Tech Development Co., Ltd. of Shanghai at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option
Manufacturers Trader OEM

Shanghai Fosun Long March Med-Tech Development Co., Ltd.

No. 830 Chengyin Road, 200444 Shanghai
China
Telephone +86 21 60765888
Fax +86 21 60765999
diagnostics@fosunpharma.com

Hall map

MEDICA 2019 hall map (Hall 3): stand J26

Fairground map

MEDICA 2019 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.01  Clinical chemistry
  • 03.01.01  Glucose testing

Glucose testing

  • 03  Diagnostic Tests
  • 03.01  Clinical chemistry
  • 03.01.05  Other equipment for clinical chemistry

Other equipment for clinical chemistry

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.04  Other equipment for immunochemistry and immunology

Other equipment for immunochemistry and immunology

  • 03  Diagnostic Tests
  • 03.04  Microbiology testing
  • 03.04.01  Bacteriology testing in microbiology

Bacteriology testing in microbiology

  • 03  Diagnostic Tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.01  DNA testing

DNA testing

  • 03  Diagnostic Tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.03  Polymerase chain reaction (PCR)

Polymerase chain reaction (PCR)

Our products

Product category: Other equipment for clinical chemistry

TBIL/DBIL

TBIL/DBIL
---Vanadate oxidization method

Features
1. Dual liquid reagent
2. Providing OEM bulk package
3. No interference while the concentration of triglyceride ≤5mmol/L, ascorbic acid ≤0.5g/L and ferrohemoglobin ≤8.0g/L
4. Stable over 18 months from date of manufacture when stored at 2° C - 25° C.

Principle & Procedure
In the acid solution (PH3), bilirubin of specimen is oxidized into bilverdin by vanadate oxidization, at the meanwhile, the absorbance at 450nm cold be decline. Based on being measured the absorbance difference value of bilirubin oxidized before and after at 450nm, the bilirubin concentration could be determined in the specimen. End-point method

More Less

Product category: Other equipment for clinical chemistry

HDL-LDL

HDL-C
HDL-CHOLESTEROL REAGENT KIT (Clearing Method)
Product Features:
1. Dual Liquid Reagent
2. Linearity ≤2.6mmol/L
3. No interference up to Triglycerides ≥1500 mg/dL, Ascorbic Acidis ≥50 mg/dL,Bilirubin ≥ 20mg/dL,Hemoglobin ≥500mg/dL
4. Stable for 30 days from once opened when stored at 2° - 8° C. 
5. Suitable for HITACHI series , YMPUS series etc automatic chemistry analyzer

LDL-C 
LDL-CHOLESTEROL REAGENT KIT (Clearing Method)
Product Features:
1. Minimum detection ≤ 5mmol/L
2. Linearity ≤11.6mmol/L
3. Recovery rate is range 90% to 110%
4. HDL/LDL-C CAL assignment is traced back to SRM 1951b

More Less

Product category: Other equipment for clinical chemistry

ADA

ADA
Assisting in diagnosis of patient in liver diseases

Features
Dual liquid reagent
Providing OEM bulk package
The linear range: 4-150U/L R2≥0.990
The assay is not interfered while the concentration of triglycerides ≤1500mg/dL ascorbic acidis≤ 50mg/dL, bilirubin≤20mg/dL and ferrohemoglobin≤50mg/dL in specimen
Shelf life is 12 months from the date of manufacture when stored at 2°C-8°C

More Less

Product category: Other equipment for clinical chemistry

AFU

AFU
----------A useful marker of hepatocellular carcinoma (HCC) 

Product features
Single liquid reagent
Providing OEM bulk package
The assay is not interfered while the concentration of triglycerides ≤ 400mg/L, bilirubin ≤100mg/dL and ferrohemoglobin ≤ 200mg/dL in specimen
Shelf life is 12 months from the date of manufacture when stored at 2°C-8°C

Intended use:
 Serum AFU activity is considered a useful marker of hepatocellular carcinoma (HCC)
 For in vitro diagnostic use only 

Principle
The AFU assay is based on the enzymatic cleavage of the synthetic substrate 2-chloro-4-nitrophenyl-a-L-fucopyranoside to a-L-fucoside and 2-chloro-4-nitrophenol, which is kinetically quantified by measuring the absorbance at 405 nm.

More Less

About us

Company details

Established in 1989, Shanghai Fosun Long March Medical Science Co., Ltd (herein after as Fosun Long March) is a high tech in-vitro diagnostics enterprise who is active in manufacturing, marketing and research and development of diagnostic and laboratory instrument and reagent. At the moment, Shanghai Fosun Long March Medical Science Co., Ltd is a wholly owned company by Shanghai Fosunpharma (Group), a China Fortune 500 company.

With product range from Clinical Chemistry kits, ELISA kits, Immunoturbidimetry kits , blood gas to electrolyte analyzer kits, we become one of the most influential brands in in-vitro diagnostics area. Our national wide sales network provides our customers products with good reputation. Being quick and efficient, our after-sales service network meets the demand of our customers whom spread throughout the country. Our products are manufactured under GMP and ISO13485 certification.

We have approximately 300 employees in the company. Fosun Long March has been rewarded with prizes by Ministry of Health, Shanghai Science and Technical Committee and Industry Associations. Also Fosun Long March has been recognized as "High-Tech Enterprise" by Shanghai Government.

<p "="" style="margin: 0px; padding: 0px; border: 0px; color: rgb(104, 104, 104); font-family: Arial, 宋体; font-size: 12px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">As the investment platform of IVD division of FosunPharma Group, Fosun Long March has speeded up merger and acquisition in the centre of new product introduction. We directly hold Yaneng Biosciences (Shenzhen) Co., Ltd, Shanghai Fosun Med-Tech Development Co., Shanghai Biofosun Biotech Co., Ltd and Jiangsu Star Diagnostics Co.,Ltd. We partly hold SINNOWA Medical Science & Technology Co., LTD and Steellex Scientific Instrument Company. At the same time, we also have close cooperation with Saladax USA, Oxford Immunotec UK, and SDB Korea through FosunPharma.

Currently the company has obtained CFDA approval for a hundred products, and more than ten patents. The imported product T-spot TB, as only authorized tuberculosis diagnosis kits in China market, filled the gaps in this field for domestic market.

<p" style="color: rgb(104, 104, 104); font-family: Arial, 宋体; font-size: 12px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Fosun Long March strives to be the leading provider of in-vitro diagnostics solutions in China. We will continue our research and development, introduction of advanced technology and cooperation with research institute in future.

More Less